Submissions from 2023
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis., Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, Youssef M K Farag, Robert Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Peter Rossing, Bertram Pitt, Gerasimos Filippatos, Stefan D Anker, George L Bakris, FIDELIO-DKD and FIGARO-DKD Investigators, and Katherine Tuttle
“Intensifying Diabetes Therapies to Achieve Personalized Treatment Goals”, Radica Alicic
Incidence of chronic kidney disease in prediabetes, Radica Alicic, Ken Daratha, Joshua J Neumiller, Katherine Tuttle, and See all authors in comments
Author Response to "Insulin Dosing Safety in CKD"., Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease., Radica Alicic, Joshua J Neumiller, and Katherine Tuttle
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease., Radica Z Alicic and Joshua J Neumiller
Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6, SC Bain, Katherine Tuttle, and See Full List of Authors in Comments
Kidney Biopsy Utility: Patient and Clinician Perspectives from the Kidney Precision Medicine Project., Lauren Bernard, Ashley R Wang, Steven Menez, Joel M Henderson, Ashveena Dighe, Glenda V Roberts, Christine Stutzke, Katherine Tuttle, R Tyler Miller, and Kidney Precision Medicine Project
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review., Riccardo Bertolo, Alessio Pecoraro, Umberto Carbonara, Daniele Amparore, Pietro Diana, Stijn Muselaers, Michele Marchioni, Maria Carmen Mir, Alessandro Antonelli, Ketan Badani, Alberto Breda, Ben Challacombe, Jihad Kaouk, Alexandre Mottrie, Francesco Porpiglia, Jim Porter, Andrea Minervini, and Riccardo Campi
A quality improvement initiative to bridge gaps in treatment and interprofessional care of chronic kidney disease, DA Cappel, Katherine Tuttle, and See all authors in comments
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)., Clara Cerrato, Margaret F Meagher, Riccardo Autorino, Giuseppe Simone, Bo Yang, Robert G Uzzo, Alexander Kutikov, Francesco Porpiglia, Umberto Capitanio, Francesco Montorsi, James R Porter, Alp T Beksac, Dhruv Puri, Mimi Nguyen, Luke Wang, Kevin Hakimi, Sohail Dhanji, Franklin Liu, Maria A Cerruto, Savio D Pandolfo, Andrea Minervini, Clayton Lau, Aron Monish, Daniel Eun, Alexandre Mottrie, Carmen Mir, Chandru Sundaram, Alessandro Antonelli, Jihad Kaouk, and Ithaar H Derweesh
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group., Clara Cerrato, Devin Patel, Riccardo Autorino, Giuseppe Simone, Bo Yang, Robert Uzzo, Francesco Porpiglia, Umberto Capitanio, James Porter, Alp Tuna Beksac, Andrea Minervini, Alessandro Antonelli, Maria Angela Cerruto, Clayton Lau, Akbar Ashrafi, Daniel Eun, Alexandre Mottrie, Carmen Mir, Margaret F Meagher, Dhruv Puri, Mimi Nguyen, Sohail Dhanji, Franklin Liu, Savio D Pandolfo, Alexander Kutikov, Francesco Montorsi, Inderbir S Gill, Chandru Sundaram, Jihad Kaouk, and Ithaar H Derweesh
Home Dialysis Curriculum Implementation for Health Care Workers Using Project ECHO Principles: A Feasibility Report From NKF-KDOQI., Christopher T Chan, Barbara Dommert-Breckler, Jordan Cannon, Renin Cassidy, Karen Crampton, Danilo Concepcion, Stephanie Hutchinson, Jessica Joseph, Rajnish Mehrotra, Gary Moore, Nancy Pierce, Matthew B Rivara, and Katy Wilkens
Metaverse Surgical Planning with Three-dimensional Virtual Models for Minimally Invasive Partial Nephrectomy., Enrico Checcucci, Daniele Amparore, Gabriele Volpi, Sabrina De Cillis, Federico Piramide, Paolo Verri, Alberto Piana, Michele Sica, Cecilia Gatti, Paolo Alessio, Alberto Quarà, Mariano Burgio, Marco Colombo, Giovanni Busacca, Alex Mottrie, Edward Cherullo, Alberto Breda, Alessandro Antonelli, Renaud Bollens, Andrea Minervini, James R Porter, Riccardo Schiavina, Riccardo Autorino, Ashutosh Tewari, Michele Di Dio, Cristian Fiori, and Francesco Porpiglia
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network., Dhruti P Chen, Margaret E Helmuth, Abigail R Smith, Pietro A Canetta, Isabelle Ayoub, Krzysztof Mucha, Mahmoud Kallash, Jeffrey B Kopp, Rasheed Gbadegesin, Brenda W Gillespie, Larry A Greenbaum, Rulan S Parekh, Tracy E Hunley, C John Sperati, David T Selewski, Jason Kidd, Aftab Chishti, Kimberly Reidy, Amy K Mottl, Debbie S Gipson, Tarak Srivastava, Katherine E Twombley, CureGN Consortium, and Katherine Tuttle
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study., Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, Ananya Roy, Rodolfo Perini, Donna Vickery, and Scott S Tykodi
Empagliflozin in Patients with Chronic Kidney Disease., The EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, Radica Alicic, Ann Cooper, and Lisa Davis
Tirzepatide decreases systolic and diastolic blood pressure., Sidar Copur, Atalay Demiray, David Cherney, Katherine Tuttle, and Mehmet Kanbay
Tirzepatide and potential use for metabolically healthy obesity., Sidar Copur, Cem Tanriover, Furkan Yavuz, Katherine R Tuttle, and Mehmet Kanbay
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?, Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine R Tuttle, and Mehmet Kanbay
Needs Assessment: Characterizing resident knowledge gaps in inpatient care of persons with Cystic Fibrosis to inform a quality improvement educational intervention, S Eglin, M Drobny, and AA Lambert
Empagliflozin in Patients with Chronic Kidney Disease., EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, and The EMPA-KIDNEY Collaborative Group
Objective assessment of intraoperative skills for robot-assisted partial nephrectomy (RAPN)., Rui Farinha, Alberto Breda, James Porter, Alexandre Mottrie, Ben Van Cleynenbreugel, Jozef Vander Sloten, Angelo Mottaran, and Anthony G Gallagher
Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study, JRS Fernandez, Katherine Tuttle, and See full list of authors in comments
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017., Rodolfo J Galindo, Shealeigh A Inselman, Guillermo E Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed K Ali, Katherine R Tuttle, and Rozalina G McCoy
960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Katherine Tuttle, and See full list of authors in comments
Long COVID and the Heart, Tyler Gluckman
Temporal Shifts In Guideline-directed Medical Therapy Prescribed At Discharge To Heart Failure Patients In A Large US Integrated Health System, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action., Hiddo Jl Heerspink, David Zi Cherney, Per-Henrik Groop, Chantal Matthieu, Peter Rossing, Katherine R Tuttle, and Janet B McGill
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis., Hiddo J L Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L Duffin, Zhengyu Yang, Russell J Wiese, Jonathan M Wilson, Andrea Hemmingway, David Z I Cherney, and Katherine Tuttle
Tirzepatide reduces albuminuria in patients with type 2 diabetes: post-hoc pooled analysis of SURPASS 1-5, Hiddo J. Heerspink, Katherine Tuttle, and See full list of authors in comments
Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease, HJL Heerspink, Katherine Tuttle, and See all authors in comments
Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with impaired kidney function., James P Johnson, Christian Diener, Anne E Levine, Tomasz Wilmanski, David L Suskind, Alexandra Ralevski, Jennifer J Hadlock, Andrew T Magis, Leroy Hood, Noa Rappaport, and Sean M Gibbons
Standardized Follow-Up Recommendations Improve Reporting of Incidental Renal Lesions in a Community Setting., Michael G Johnston, Skyler Burke, Chance M Brock, Saralyn Beckius, and Scott King
The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis., Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah B Yildiz, Metehan Berkkan, Kathherine R Tuttle, and Carmine Zoccali
The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis., Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah B Yildiz, Metehan Berkkan, Kathherine R Tuttle, and Carmine Zoccali
Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials., Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah Burak Yildiz, Abduzhappar Gaipov, Daniel H van Raalte, and Katherine Tuttle
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association., Sadiya S Khan, Josef Coresh, Michael J Pencina, Chiadi E Ndumele, Janani Rangaswami, Sheryl L Chow, Latha P Palaniappan, Laurence S Sperling, Salim S Virani, Jennifer E Ho, Ian J Neeland, Katherine Tuttle, Radhika Rajgopal Singh, Mitchell S V Elkind, Donald M Lloyd-Jones, and American Heart Association
Real-World Outcomes of Impella 5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry, A Kilic, Jacob Abraham, and See full list of authors in comments
Transcatheter Aortic Valve Replacement Outcomes in End-Stage Renal Disease Patients on Hemodialysis Requiring Midodrine., Ethan C Korngold, Ruyun Jin, Kateri Spinelli, V Kumar, Brydan Curtis, Sameer Gafoor, Derek Phan, Daniel Spoon, Aidan Raney, Lisa McCabe, and Brandon Jones
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease., Jill R Krissberg, Michelle M O'Shaughnessy, Abigail R Smith, Margaret E Helmuth, Salem Almaani, Diego H Aviles, Kaye E Brathwaite, Yi Cai, Daniel Cattran, Rasheed Gbadegesin, Dorey A Glenn, Larry A Greenbaum, Sandra Iragorri, Koyal Jain, Myda Khalid, Jason Kidd, Jeffrey Kopp, Richard Lafayette, Jerome C Lane, Francesca Lugani, Jordan G Nestor, Rulan S Parekh, Kimberly Reidy, David T Selewski, Christine B Sethna, C John Sperati, Katherine Tuttle, Katherine Twombley, Tetyana L Vasylyeva, Donald J Weaver, Scott E Wenderfer, Keisha Gibson, and CureGN Consortium
Assessment of medication adherence among adults with glomerular disease, JR Krissberg, Katherine Tuttle, and See all authors in comments
The Effect of Preoperative Carbohydrate Intake on Length of Stay and Postoperative Recovery Following Laparoscopic Living Donor Nephrectomy., Morgan Kuiper, Melanie Gillingham, Julie Martin, Daniella Gardner, and Sandra Van Calcar
“Research Coordinator Mentoring Program – Participant Presentations”, Kelli Kuykendall
Equity and Quality of Global CKD Care - what are we waiting for?, Valerie A Luyckx, Ayah Elmaghrabi, Manisha Sahay, Nicole Scholes-Robertson, Laura Sola, Tobias Speare, Elliot K Tannor, Katherine Tuttle, and Ikechi G Okpechi
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis., Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder, Viji Nair, Felix Eichinger, Sebastian Martini, Adebowale D Ademola, Vincent Boima, Heather N Reich, Jamal El Saghir, Bradley Godfrey, Wenjun Ju, Emily C Tanner, Virginia Vega-Warner, Noel L Wys, Sharon G Adler, Gerald B Appel, Ambarish Athavale, Meredith A Atkinson, Serena M Bagnasco, Laura Barisoni, Elizabeth Brown, Daniel C Cattran, Gaia M Coppock, Katherine M Dell, Vimal K Derebail, Fernando C Fervenza, Alessia Fornoni, Crystal A Gadegbeku, Keisha L Gibson, Laurence A Greenbaum, Sangeeta R Hingorani, Michelle A Hladunewich, Jeffrey B Hodgin, Marie C Hogan, Lawrence B Holzman, J Ashley Jefferson, Frederick J Kaskel, Jeffrey B Kopp, Richard A Lafayette, Kevin V Lemley, John C Lieske, Jen-Jar Lin, Rajarasee Menon, Kevin E Meyers, Patrick H Nachman, Cynthia C Nast, Michelle M O'Shaughnessy, Edgar A Otto, Kimberly J Reidy, Kamalanathan K Sambandam, John R Sedor, Christine B Sethna, Pamela Singer, Tarak Srivastava, Cheryl L Tran, Katherine Tuttle, Suzanne M Vento, Chia-Shi Wang, Akinlolu O Ojo, Dwomoa Adu, Debbie S Gipson, Howard Trachtman, and Matthias Kretzler
Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study, LH Mariani, Katherine Tuttle, and See all authors in comments
Comparison of in-clinic only to in-clinic plus virtual mental health screens of adults with cystic fibrosis during SARS-CoV-2 pandemic, KG Mertz, M Ingoldby, T Vance, and AA Lambert
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine Tuttle
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine R Tuttle
Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, JE Milton, A Chavez, K Kuykendall, and AA Lambert
Quality Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, Joan Milton
“Cardiac Amyloid Pearls & Pitfalls”, Deirdre Mooney
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update., Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Adrian Liew, Erin D Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H de Boer, and Kamlesh Khunti
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A Scientific Statement from the American Heart Association., C Ndumele, Katherine Tuttle, and See all authors in comments
First-line therapy in T2D: Has Metformin been “dethroned, Joshua J Neumiller and Radica Alicic
Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Alicic, and Jenny Shen
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Z Alicic, and Jenny Shen
Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020., Susanne B Nicholas, Kenn Daratha, Radica Alicic, Cami R Jones, Lindsey M Kornowske, Joshua J Neumiller, Samuel T Fatoba, Sheldon X Kong, Rakesh Singh, Keith C Norris, and Katherine Tuttle
Operative and oncological outcomes of salvage robotic radical and partial nephrectomy: a multicenter experience., Kennedy E Okhawere, Ralph Grauer, Laura Zuluaga, Kirolos N Meilika, Burak Ucpinar, Alp Tuna Beksac, Shirin Razdan, Indu Saini, Chiya Abramowitz, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Michael D Stifelman, Mani Menon, and Ketan K Badani
Transperitoneal Versus Retroperitoneal Robotic-Assisted Partial Nephrectomy in Patients with Obesity., Kennedy E Okhawere, Jordan Miller Rich, Alp Tuna Beksac, Laura Zuluaga, Indu Saini, Burak Ucpinar, Joshua Levieddin, Iretiayo T Joel, Anthony Deluxe, Michael D Stifelman, Simone Crivellaro, Ronney Abaza, Daniel D Eun, Akshay Bhandari, Ashok K Hemal, James Porter, Ahmed Mansour, Phillip M Pierorazio, Osama Zaytoun, and Ketan K Badani
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Michael J Jaasma, Elizabeth S Brooks, Deborah R Edgar, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, and Nagy A Mekhail
Spontaneous Rupture of a Previously Asymptomatic Giant Angiomyolipoma, Reed Ritterbusch
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease., Kyle M Rose, Katie S Murray, Craig Labbate, Solomon Woldu, Jennifer Linehan, Joseph Jacob, Hristos Kaimakliotis, Rian Dickstein, Adam Feldman, Surena F Matin, Yair Lotan, Mitchell R Humphreys, and Wade J Sexton
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
1460-P: Prevalence of Chronic Kidney Disease Associated with Type 1 Diabetes in the U.S., Peter Rossing, Per-Henrik Groop, Rakesh Singh, Robert Lawatscheck, and Katherine Tuttle
Phase II doseselection, randomized double-blind trial of the ASI, BI 690517, alone and in combination with EMPA in people with CKD, P Rossing, Katherine Tuttle, and Full List of Authors in Comments
Prevalence of chronic kidney disease associated with type 1 diabetes in the US, P Rossing, Katherine Tuttle, and See full list of authors in comments
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial., William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Robin S Goland, Peter A Gottlieb, Carla J Greenbaum, Michael J Haller, Jeffrey P Krischer, Ingrid M Libman, Peter S Linsley, S Alice Long, Sandra M Lord, Daniel J Moore, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Philip Raskin, Jay S Skyler, John M Wentworth, Diane K Wherrett, Darrell M Wilson, Anette-Gabriele Ziegler, and Kevan C Herold
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis., Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R Tuttle, Luis M Ruilope, Peter Rossing, Robert Toto, Stefan D Anker, Zhi-Hong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George Bakris, and FIDELIO-DKD and FIGARO-DKD Investigators
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis., Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishanan Sivaraman, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database study., Gopal Sharma, Gurpremjit Singh, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Sivaraman Ananth, James R Porter, Craig Rogers, Alexandre Mottrie, Ronney Abaza, Khoon Ho Rha, Daniel Moon, Thyavihally B Yuvaraja, Dipen J Parekh, Umberto Capitanio, Kris K Maes, Francesco Porpiglia, Levent Turkeri, and Gagan Gautam
Response to COVID-19: The Outpatient Dialysis Setting., Jeffrey Silberzweig, Sylvia Wu, Matthew Sinclair, Thomas Watson, Nancy Welder, Danilo Concepcion, Jerry Yee, Felicia Speed, Daniel Cukor, Brigitte Schiller, and Daniel Weiner
2023 Cardiometabolic Health Congress (CMHC) Women’s Health and Wellness Masterclass, Katherine Tuttle
“90% of people with chronic kidney disease don’t know they have it. Do you know the risk factors?”, Katherine Tuttle
CKD in Diabetes and the Journey to Kidney Health, Katherine Tuttle
Clinicopathologic Conference “ Nephrotic Syndrome”, Katherine Tuttle
Destination Kidney Health for Diabetes and CKD, Katherine Tuttle
Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle
Effects of Long COVID, Katherine Tuttle
“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”, Katherine Tuttle
“FDA approves new indication for Jardiance”, Katherine Tuttle
“GLP1 RAs and Kidney Outcomes in Diabetes”, Katherine Tuttle
Harvard Medical School – Diabetes Comorbidities and Complications, Katherine Tuttle
“Jardiance approved for adults with Chronic Kidney Disease”, Katherine Tuttle
KDIGO Conference on CKD, Rome Italy, Katherine Tuttle
Kidney Health in View for Diabetes and CKD, Katherine Tuttle
Late breaking clinical trials: “Asi in CKD”, Katherine Tuttle
Most Powerful Tools Ever to Slow the Progression of Diabetic Kidney Disease: How and When to Use them Optimally”, Katherine Tuttle
Multidisciplinary Strategies for Implementation, Katherine Tuttle
“On par with the biggest breakthroughs in medicine”, Katherine Tuttle
“Outsize benefit seen in trial of drug for kidney disease”, Katherine Tuttle
“Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study”, Katherine Tuttle
“Preserving Kidney Health in Diabetes”, Katherine Tuttle
Protective effects of GLP-1 Receptor Agonists, Katherine Tuttle
“Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”, Katherine Tuttle
